BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12118249)

  • 1. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling.
    Su TT; Guo B; Kawakami Y; Sommer K; Chae K; Humphries LA; Kato RM; Kang S; Patrone L; Wall R; Teitell M; Leitges M; Kawakami T; Rawlings DJ
    Nat Immunol; 2002 Aug; 3(8):780-6. PubMed ID: 12118249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
    Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
    Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells.
    Bone H; Williams NA
    Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-induced immune suppression is associated with NF-kappaB activation via conventional PKC isotypes in lipopolysaccharide-stimulated 70Z/3 pre-B lymphocyte tumor cells.
    Lee M; Jeon YJ
    Mol Pharmacol; 2001 Feb; 59(2):248-53. PubMed ID: 11160860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
    Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
    Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor-induced lipid raft recruitment of the I kappa B kinase complex is necessary and sufficient for NF-kappa B activation occurring in the cytosol.
    Sebald A; Mattioli I; Schmitz ML
    Eur J Immunol; 2005 Jan; 35(1):318-25. PubMed ID: 15597322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective role of PKCbeta enzymatic function in regulating cell survival mediated by B cell antigen receptor cross-linking.
    Venkataraman C; Chen XC; Na S; Lee L; Neote K; Tan SL
    Immunol Lett; 2006 May; 105(1):83-9. PubMed ID: 16564096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades.
    Matsubara M; Tamura T; Ohmori K; Hasegawa K
    Biochem Pharmacol; 2005 Feb; 69(3):433-49. PubMed ID: 15652235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.
    Lu Y; Jamieson L; Brasier AR; Fields AP
    Oncogene; 2001 Aug; 20(35):4777-92. PubMed ID: 11521190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C family functions in B-cell activation.
    Guo B; Su TT; Rawlings DJ
    Curr Opin Immunol; 2004 Jun; 16(3):367-73. PubMed ID: 15134787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinase GLK controls autoimmunity and NF-κB signaling by activating the kinase PKC-θ in T cells.
    Chuang HC; Lan JL; Chen DY; Yang CY; Chen YM; Li JP; Huang CY; Liu PE; Wang X; Tan TH
    Nat Immunol; 2011 Oct; 12(11):1113-8. PubMed ID: 21983831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of the CARMA1 linker controls NF-kappaB activation.
    Sommer K; Guo B; Pomerantz JL; Bandaranayake AD; Moreno-García ME; Ovechkina YL; Rawlings DJ
    Immunity; 2005 Dec; 23(6):561-74. PubMed ID: 16356855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of zeta PKC in B-cell signaling and function.
    Martin P; Duran A; Minguet S; Gaspar ML; Diaz-Meco MT; Rennert P; Leitges M; Moscat J
    EMBO J; 2002 Aug; 21(15):4049-57. PubMed ID: 12145205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehending the complex connection between PKCbeta, TAK1, and IKK in BCR signaling.
    Shinohara H; Kurosaki T
    Immunol Rev; 2009 Nov; 232(1):300-18. PubMed ID: 19909372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C-alpha is essential for Ramos-BL B cell survival.
    Keenan C; Thompson S; Knox K; Pears C
    Cell Immunol; 1999 Sep; 196(2):104-9. PubMed ID: 10527562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
    Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of atypical protein kinase C isozymes and NF-kappaB in IL-1beta-induced expression of cyclooxygenase-2 in human myometrial smooth muscle cells.
    Duggan SV; Lindstrom T; Iglesias T; Bennett PR; Mann GE; Bartlett SR
    J Cell Physiol; 2007 Mar; 210(3):637-43. PubMed ID: 17133356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The signal transduction pathway of CD23 (Fc epsilon RIIb) targets I kappa B kinase.
    Ten RM; McKinstry MJ; Trushin SA; Asin S; Paya CV
    J Immunol; 1999 Oct; 163(7):3851-7. PubMed ID: 10490984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.